Clinical Trial

To Evaluate the Safety and Efficacy of Pediococcus Acidilactici PA53 in Relieving Constipation in Adults

Completed
View on ClinicalTrials.gov →
Summary
To study the improvement of constipation symptoms, quality of life and mental state, intestinal function, intestinal hormones, inflammation and immunity, and intestinal flora of constipation subjects after 8-week intervention with Pediococcus acidilactici PA53.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-30
notable Enrollment increased: 10 -> 87 participants 2026-07-30
notable Primary completion pushed: 2025-04-25 -> 2025-06-03 2026-07-30
Trial Details
NCT Number NCT06761443
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Constipation
Enrollment 87 participants
Start Date 2025-01-03
Primary Completion 2025-06-03 (estimated)
Study Completion 2025-06-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-29